BioPlus Co Ltd
KOSDAQ:099430
BioPlus Co Ltd
Total Liabilities
BioPlus Co Ltd
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Total Liabilities
₩130.8B
|
CAGR 3-Years
138%
|
CAGR 5-Years
111%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Total Liabilities
₩551.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
|
SD Biosensor Inc
KRX:137310
|
Total Liabilities
₩965.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
93%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Total Liabilities
₩326.2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
28%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Total Liabilities
₩25.6B
|
CAGR 3-Years
46%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Total Liabilities
₩65.4B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
13%
|
|
BioPlus Co Ltd
Glance View
BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.
See Also
What is BioPlus Co Ltd's Total Liabilities?
Total Liabilities
130.8B
KRW
Based on the financial report for Dec 31, 2024, BioPlus Co Ltd's Total Liabilities amounts to 130.8B KRW.
What is BioPlus Co Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
111%
Over the last year, the Total Liabilities growth was 191%. The average annual Total Liabilities growth rates for BioPlus Co Ltd have been 138% over the past three years , 111% over the past five years .
